Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01546142 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

516

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate or Severe Submental Fullness

Interventions

DRUG: Deoxycholic acid injection
DRUG: Placebo

Sponsor

Kythera Biopharmaceuticals